David van Ass
David is an associate director at Oaklins Netherlands, with particular expertise in TMT. He advised the management of Avantium on its IPO and has worked on several sell-side transactions, including the sale of Fysicon to Canon Medical Systems Corporation, the sale of DearBytes to KPN, the sale of Multi Pilot Simulations to H2 Equity Partners, the sale of SurfRight to Sophos, the sale of Infradata to Waterland Private Equity and the sale of CDC to G Square Healthcare. He also successfully worked on the US$55.4 million IPO of Dutch Star Companies ONE on Euronext Amsterdam.
David joined Oaklins Netherlands in 2014 after completing an internship there. He has a master’s in behavioral economics from Erasmus University Rotterdam.